The introduction of nicotinamide for a nicotine substitute in e-cigarette and smokeless merchandise represents a major regulatory problem for your FDA. Nicotinamide doesn't have nicotinic receptor agonist activity and is understood to act as a sedative at large dosages6. The promises created by Nicotine River, ECBlend, and other sellers that their